id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2017-P-4249-0006,FDA,FDA-2017-P-4249,Withdrawal from GE Healthcare Inc,Other,Withdrawal,2017-12-26T05:00:00Z,2017,12,2017-12-26T05:00:00Z,,2017-12-26T18:13:47Z,,0,0,0900006482d738a2
FDA-2017-P-4249-0002,FDA,FDA-2017-P-4249,Attachment 1 Orange Book Product Listing Dotarem re Suitability Petition from GE Healthcare Inc,Supporting & Related Material,Background Material,2017-07-14T04:00:00Z,2017,7,,,2017-07-14T19:42:22Z,,0,0,0900006482923ca8
FDA-2017-P-4249-0004,FDA,FDA-2017-P-4249,Attachment 2 Dotarem approved label re Suitability Petition from GE Healthcare Inc,Supporting & Related Material,Background Material,2017-07-14T04:00:00Z,2017,7,,,2017-07-14T19:44:27Z,,0,0,0900006482924167
FDA-2017-P-4249-0001,FDA,FDA-2017-P-4249,Suitability Petition from GE Healthcare Inc,Other,Citizen Petition,2017-07-14T04:00:00Z,2017,7,2017-07-14T04:00:00Z,2018-01-11T04:59:59Z,2017-07-14T19:41:36Z,,0,0,0900006482923ca3
FDA-2017-P-4249-0003,FDA,FDA-2017-P-4249,Acknowledgement Letter from FDA DDM to GE Healthcare Inc,Other,Acknowledgement Letter/Receipt,2017-07-14T04:00:00Z,2017,7,2017-07-14T04:00:00Z,,2017-07-14T19:44:19Z,,0,0,0900006482923ca6
FDA-2017-P-4249-0005,FDA,FDA-2017-P-4249,Attachment 3 Draft labeling for the proposed 5mL product re Suitability Petition from GE Healthcare Inc,Supporting & Related Material,Background Material,2017-07-14T04:00:00Z,2017,7,,,2017-07-14T19:44:30Z,,0,0,0900006482924168